Biotechnology Value Fund L P

13F Holdings History for Protagonist Therapeutics, Inc - Common Stock, par value $0.00001 (PTGX)

Symbol: PTGX on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001
Latest Disclosed Ownership: 2.56M shares
Security Ownership: 4.1%

BVF PARTNERS L P/IL ownership in Protagonist Therapeutics, Inc Common Stock, par value $0.00001 (PTGX)

2025-11-14 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.56M shares of Protagonist Therapeutics, Inc Common Stock, par value $0.00001 (PTGX). This represents 4.1% percent ownership of the company. In their previous filing dated 2025-06-16, BIOTECHNOLOGY VALUE FUND L P had reported owning 3.21M shares, indicating a decrease of -20.2% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
BVF PARTNERS L P/IL	4.1%	-22%	$170M	2.56M	-650,125	-20.2%	$66.43	13G/A	9/30/2025	14 Nov 2025 16:17:42
BVF PARTNERS L P/IL	5.2%		$147M	3.21M			$45.82	13G	6/9/2025	16 Jun 2025 17:30:24